DHR
DANAHER CORP /DE/
NYSE · Healthcare · Medical - Diagnostics & Research · US
$234.38
+1.86%Oct 22, 2026, 08:00 UTC
Genedata AG announced that it had added NVIDIA CORP’s RFD4-Proteina binder-design model to its AI-enabled production discovery workflows.
Source:Oct 21, 2026, 15:46 UTC
DANAHER CORP /DE/ raised its adjusted earnings outlook for 2026.
Source:Oct 21, 2026, 12:26 UTC
DANAHER CORP /DE/ reported quarterly earnings of $2.11 per share, above the Zacks Investment Research, Inc. consensus estimate of $1.92 and compared with $1.89 per share a year earlier.
Sep 30, 2026, 15:36 UTC
Danaher's Biotechnology segment posted 4% sales growth, though tough comparisons and shipment timing could test its momentum.
Source:Sep 22, 2026, 08:22 UTC
China's Vice Minister of Commerce and International Trade Representative Ling Ji visited Zhongguancun Life Science Park in Beijing and chaired a roundtable with more than 30 foreign-funded enterprises on September 21.
Source:Aug 17, 2026, 00:48 UTC
NANO Holdings announced that Jack Yamamori, with extensive M&A and management experience in the US, was appointed Vice Chairman in August 2026 to accelerate investment business growth.
Source:Aug 10, 2026, 17:15 UTC
Masimo appointed Tim Benner as president, succeeding Katie Szyman who stepped down in June, following the company's acquisition by Danaher.
Source:Jun 24, 2026, 17:55 UTC
Danaher acquired Masimo for $9.9 billion, expanding into clinical patient monitoring.
Source:Jun 12, 2026, 15:06 UTC
Danaher Corporation completed its $9.9 billion acquisition of Masimo Corporation, adding AI-enabled patient-monitoring and sensor technologies to its product portfolio.
Source:Jun 10, 2026, 12:55 UTC
Danaher Corporation completed its acquisition of Masimo Corporation.
Source: